Blissco gets Sale LicenseGood news for us too!
Friday, November 16, 2018, 8:00 AM ET
BlissCo Receives Cannabis Sales License from Health Canada
Not for distribution in the U.S. or to U.S. Newswires
VANCOUVER, British Columbia, Nov. 16, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) ("BlissCo" or the "Company"), is pleased to announce that it has received a comprehensive sales license from Health Canada to sell bulk cannabis and pre-packaged, labeled, and tested cannabis products.
"We are thrilled to receive our sales license and to be able to start pre-registering clients and supplying both the robust medical and adult-use markets in Canada with our premium cannabis products," said Damian Kettlewell, CEO of BlissCo. "BlissCo is committed to providing top-tier service to all of our customers."
The Company will soon be launching its e-commerce website and BlissConnect, a telemedicine app for medical cannabis consultations, to service its medical clients. The Company is currently ready to pre-register clients wishing to be first in line when shipping begins. To pre-register, clients can call the BlissCo Client Care line at 1-877-310-BLIS (2547) between the hours of 9:00 am to 5:00 pm PST or email hello@blissco.com.
About BlissCo Cannabis Corp.
BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is a wellness-focused, licensed producer, processor, and distributor of ultra-premium cannabis.
BlissCo is committed to providing distinguished customer service and offering innovative cannabis products. The Company leverages the latest technology and is continuously developing its network of top-tier industry experts. BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo's patients and customers.
Learn more: BlissCo.com
On Behalf of the Board of Directors
BLISSCO CANNABIS CORP.
Damian Kettlewell, CEO, Founder & Chair
For further information please contact:
Ariel Jack Lewinski, Business Development & Investor Relations
# 1-604-377-7533
ariel.lewinski@blissco.com